91 related articles for article (PubMed ID: 2043891)
21. [Autologous bone marrow transplantation in malignant hematogenous tumor of adults--the current status and problems in Japan].
Harada M; Asano S
Rinsho Ketsueki; 1992 Jul; 33(7):934-9. PubMed ID: 1507415
[No Abstract] [Full Text] [Related]
22. [Detection of minimal residual disease in childhood hematological malignancies and its clinical significance].
Tang S; Lu S; Zhang X; Ran C; Huang D; Wei X
Zhonghua Xue Ye Xue Za Zhi; 2000 Jan; 21(1):27-9. PubMed ID: 11876957
[TBL] [Abstract][Full Text] [Related]
23. Purging in BCR-ABL-positive acute lymphoblastic leukemia using immunomagnetic beads: comparison of residual leukemia and purging efficiency in bone marrow vs peripheral blood stem cells by semiquantitative polymerase chain reaction.
Atta J; Fauth F; Keyser M; Petershofen E; Weber C; Lippok G; Hoelzer D; Martin H
Bone Marrow Transplant; 2000 Jan; 25(1):97-104. PubMed ID: 10654022
[TBL] [Abstract][Full Text] [Related]
24. The detection of wt-1 transcripts is not associated with an increased leukemic relapse rate in patients with acute leukemia after allogeneic bone marrow or peripheral blood stem cell transplantation.
Elmaagacli AH; Beelen DW; Trenschel R; Schaefer UW
Bone Marrow Transplant; 2000 Jan; 25(1):91-6. PubMed ID: 10654021
[TBL] [Abstract][Full Text] [Related]
25. Detection of minimal residual disease in leukemia using polymerase chain reaction and restriction analysis.
Wu N; Lu S; Zhu P; Liu L; Peng Y
Chin Med J (Engl); 1997 Jan; 110(1):73-7. PubMed ID: 9594329
[TBL] [Abstract][Full Text] [Related]
26. [The contribution of cytogenetics to the evaluation of residual disease in malignant hemopathies].
Bertheas MF; Fraisse J; Vasselon C; Jaubert J; Frappaz D; Freycon F; Brizard CP
Pathol Biol (Paris); 1988 Jan; 36(1):52-5. PubMed ID: 3283672
[TBL] [Abstract][Full Text] [Related]
27. Bone marrow minimal disseminated disease (MDD) and minimal residual disease (MRD) in childhood T-cell lymphoblastic lymphoma stage III, detected by flow cytometry (FC) and real-time quantitative polymerase chain reaction (RQ-PCR).
Stark B; Avigad S; Luria D; Manor S; Reshef-Ronen T; Avrahami G; Yaniv I
Pediatr Blood Cancer; 2009 Jan; 52(1):20-5. PubMed ID: 19006253
[TBL] [Abstract][Full Text] [Related]
28. [Detection of residual malignant cells in patients with hematopoietic malignancy].
Irimajiri K
Rinsho Ketsueki; 1993 May; 34(5):537-44. PubMed ID: 8315824
[TBL] [Abstract][Full Text] [Related]
29. Detection of minimal residual disease in patients with childhood common acute lymphoblastic leukemia after autologous bone marrow transplantation with ex vivo purging and systemic IL-2 infusion: unsuccessful prediction of subsequent relapse.
Kiyoi H; Kojima S; Kato K; Matsuyama T; Kodera Y; Ohno R; Naoe T
Bone Marrow Transplant; 1995 Sep; 16(3):437-42. PubMed ID: 8535317
[TBL] [Abstract][Full Text] [Related]
30. [Significance of dynamic detection of WT1 expression on monitoring minimal residual disease in leukemia patients following allogeneic bone marrow transplantation].
Gu WY; Chen ZX; Hu SY; Zhu J; Wang ZL; Yan F; Wang W; Cen JN; Shen HL; Qian J
Zhonghua Yi Xue Za Zhi; 2005 Feb; 85(7):444-7. PubMed ID: 15854547
[TBL] [Abstract][Full Text] [Related]
31. Allogeneic bone marrow transplantation in haematological malignancies. Leukemia Working Party of the European Group for Bone Marrow Transplantation (EBMT).
Gahrton G; Gratwohl A; Ernst P; Hermans J; Lyklema A; Zwaan FE
Bone Marrow Transplant; 1989 Dec; 4 Suppl 4():4-6. PubMed ID: 2627623
[No Abstract] [Full Text] [Related]
32. Evaluation of mixed chimerism in bone marrow transplantation program in Croatia.
Grubic Z; Stingl K; Cecuk-Jelicic E; Zunec R; Serventi Seiwerth R; Labar B; Rajic Lj; Brkljacic-Kerhin V
Transplant Proc; 2005 Mar; 37(2):1388-91. PubMed ID: 15848729
[TBL] [Abstract][Full Text] [Related]
33. Autologous bone marrow transplantation.
Kochupillai V; Kumar L; Anandhi R
Indian J Pathol Microbiol; 1991 Apr; 34(2):152-9. PubMed ID: 1752645
[No Abstract] [Full Text] [Related]
34. [Detection of minimal residual leukemia after bone marrow transplantation in patients with chronic myeloid leukemia using the polymerase chain reaction].
Matsue K; Nakamura K; Mizutani S
Rinsho Ketsueki; 1990 May; 31(5):603-8. PubMed ID: 2395211
[TBL] [Abstract][Full Text] [Related]
35. [Treatment of neoplastic hematologic diseases with intensive radio-chemotherapy and transplantation of cryopreserved autologous bone marrow].
Nemet D; Labar B; Bogdanić V; Kolevska T; Mrsić M; Pavletić Z; Kalenić S; Vrtar M; Marusić M; Markulin-Grgić L
Lijec Vjesn; 1989; 111(9-10):348-53. PubMed ID: 2633014
[TBL] [Abstract][Full Text] [Related]
36. Outcome prediction by molecular detection of minimal residual disease in bone marrow for advanced neuroblastoma.
Horibe K; Fukuda M; Miyajima Y; Matsumoto K; Kondo M; Inaba J; Miyashita Y
Med Pediatr Oncol; 2001 Jan; 36(1):203-4. PubMed ID: 11464885
[TBL] [Abstract][Full Text] [Related]
37. [Residual disease: the hematologist's point of view].
Quesnel B; Preudhomme C
Bull Cancer; 2001 Jun; 88(6):571-5. PubMed ID: 11459703
[TBL] [Abstract][Full Text] [Related]
38. Long-term culture of canine marrow: cytogenetic evaluation of purging of lymphoma and leukemia.
Carter RF; Kruth SA; Valli VE; Dubé ID
Exp Hematol; 1990 Oct; 18(9):995-1001. PubMed ID: 2397754
[TBL] [Abstract][Full Text] [Related]
39. CD56+CD7+ stem cell leukemia/lymphoma with D2-Jdelta1 rearrangement.
Yoshida T; Kimura N; Sawada H; Suematsu E; Nagano M; Akiyoshi T; Motomura S; Kikuchi M; Nishimura J; Tamura K
Intern Med; 1999 Jul; 38(7):547-55. PubMed ID: 10435360
[TBL] [Abstract][Full Text] [Related]
40. [Diagnosis of minimal residual disease in autologous bone marrow transplantation].
Jørgensen H; Bukh A; Hokland P; Ellegaard J; Madsen PS; Hokland M
Nord Med; 1996 Dec; 111(10):344-7. PubMed ID: 8992466
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
